A follow-up study of balloon angioplasty and de-novo stenting in Takayasu arteritis
Introduction
Takayasu Arteritis is a sizeable problem in Japan and South Asian countries including India [1]. The management of Takayasu Arteritis (TA) is challenging. Steroids and immuno-suppressive agents have been used with variable success [2], [3], [4], [5]. Revascularisation procedures are usually performed for significant stenotic lesions in TA [6]. Although percutaneous transluminal balloon angioplasty (PTBA) is an established treatment for the management of atherosclerotic coronary and non-coronary vascular stenotic lesions and non-atherosclerotic stenotic peripheral arterial lesions, however, restenosis remains a major concern with PTBA [7], [8]. Stent supported angioplasty achieves better luminal diameter and lowers the rate of restenosis [8], [9]. We are reporting our experience with 20 patients of TA who underwent angioplasty and de-novo stenting and were followed for a minimum period of 6 months.
Section snippets
Material and methods
Twenty patients of angiographically proven TA were included in the study. All patients underwent a detailed clinical evaluation and laboratory investigations. The patients with disease activity as judged by systemic features – fever, musculoskeletal pains, vascular ischaemia or raised erythrocyte sedimentation rate of more than 20 mm in the first hour were given steroids (Prednisolone 2 mg/kg). The doses of steroid were adjusted according to the erythrocyte sedimentation rate and clinical
Technique
An informed and a written consent was obtained from all patients prior to the procedure. All procedures were performed under local anaesthesia through the right femoral or brachial punctures using the Schneider technique. Direct surgical exposure of artery was done for percutaneous access to the vessel where required. Heparin was given as bolus during the procedure to maintain an activated coagulation time between 250 and 300 s.
Angioplasty was performed using the standard coaxial
Results
Of the 20 patients, there were 11 males and 9 females with a mean age of 28±13.1 years. Hypertension was present in 18 (90%), fatigue in 13 (65%)and headache in 11 (55%) of the patients. Vascular bruits were heard in 12 (60%) patients. Two patients presented with congestive heart failure. Laboratory investigations revealed an elevated erythrocyte sedimentation rate (more than 20 mm/h) in 6 patients and left ventricular hypertrophy on electrocardiographic in 5 patients. Angiographic findings
Discussion
The management strategies of TA include medical therapy with steroids or immunosuppressive agents and revascularization procedure [2], [3], [4], [5]. During the active phase of the disease, steroids have been shown to improve the systemic inflammatory symptoms within a few days to weeks. Absent pulses may appear in up to 50% of cases. Cytotoxic drugs – methotrexate or cyclophosphamide, have been used when steroids could not induce remission [3], [5].
In the chronic stage, the principle of
References (19)
Effect of Prednisolone therapy on arterial angiographic features in Takayasu’s disease
Am J Cardiol
(1991)- et al.
Percutaneous transluminal angioplasty in Takayasu’s arteritis: Persistent benefit over two years
Am Heart J
(1990) - et al.
Stent supported angioplasty in Takayasu arteritis
Int J Cardiol
(1998) - et al.
Balloon angiography for renovascular hypertension in Takayasu arteritis
Am Heart J
(1993) - et al.
Percutaneous transluminal angioplasty of subclavian artery in nonspecific aortoarteritis: Results of long term follow up
J Vasc Intern Radiol
(1994) - et al.
Takayasu’s arteritis in India
Heart Vessels
(1992) - et al.
Treatment of glucocorticoid resistant or relapsing Takayasu arteritis with Methotrexate
Arthritis Rheum
(1994) - et al.
Takayasu arteritis
Ann Intern Med
(1994) Percutaneous transluminal angioplasty for renovascular hypertension in arteritis: Experience in China
Radiology
(1987)
Cited by (114)
Long-Term Follow-Up of Endovascular Repair in the Management of Arterial Stenosis Caused by Takayasu's Arteritis
2017, Annals of Vascular SurgeryTransradial retrograde percutaneous transluminal angioplasty with stenting of long segment occlusion of subclavian artery
2017, Journal of Cardiology CasesSelective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu arteritis: Two-year results
2016, International Journal of CardiologyCitation Excerpt :Revascularization, including surgical and endovascular procedures, has been applied in the management of symptomatic RASTA [5–7]. Percutaneous transluminal angioplasty (PTA) was most widely used in patients with RASTA, however angiographic outcomes are discontented in considerable cases because of accompanying recoil or dissection after plain balloon angioplasty [8,9]. If PTA fails, then stent placement is another candidate therapeutic procedure [8,9].
Endovascular revascularization for carotid artery occlusion in patients with Takayasu arteritis
2015, European Journal of Vascular and Endovascular SurgeryCitation Excerpt :Further angioplasty treatment in a stepwise fashion should be performed at least 1–3 months later to minimize the possibility of unpredictable complications, such as local dissection and thrombosis. Some reports show that angioplasty and stent placement in TA can be performed with excellent immediate results.18,19 For them, the majority were limited to short focal stenotic lesions with no complete occlusions.
Endovascular Treatment of Large Vessel Arteritis
2014, Techniques in Vascular and Interventional RadiologyTakayasu's arteritis associated with Crohn's disease
2014, Revista Clinica Espanola